Watanabe, Sho
Shimoi, Tatsunori
Nishikawa, Tadaaki
Kawachi, Asuka
Okuma, Hitomi Sumiyoshi
Tokura, Momoko
Yazaki, Shu
Mizoguchi, Chiharu
Arakaki, Motoko
Saito, Ayumi
Kita, Shosuke
Yamamoto, Kasumi
Kojima, Yuki
Sudo, Kazuki
Noguchi, Emi
Yoshida, Akihiko
Kawai, Akira
Fujiwara, Yasuhiro
Yonemori, Kan
Article History
Received: 20 December 2022
Accepted: 24 June 2023
First Online: 3 July 2023
Competing interests
: T.N. received institutional support from Daiichi-Sankyo, institutional grants or contracts from AstraZeneca, and honoraria for speakers’ bureaus from AstraZeneca, Chugai, Takeda, MSD, Eisai, and Taiho Pharmaceutical. A.K. received payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing, and educational events from Daiichi-Sankyo and Taiho Pharmaceutical. K.Y. received grants for an advisory role from Novartis, Eisai, AstraZeneca, Chugai, Takeda, Genmab, and OncXerna; honoraria for lectures from Pfizer, Eisai, AstraZeneca, Eli Lilly, Takeda, Chugai, Fuji Film Pharma, MSD, Boehringer Ingelheim, Ono Pharmaceutical, and Daiichi-Sankyo; and institutional financial support from MSD, Daiichi-Sankyo, AstraZeneca, Taiho Pharmaceutical, Pfizer, Novartis, Takeda, Chugai, Ono Pharmaceutical, Sanofi, Seattle Genetics, Eisai, Eli Lilly, Genmab, Boehringer Ingelheim, Kyowa Hakko Kirin, Nihon Kayaku, and Haihe. All other authors declare no competing financial interests.